Install
- 944articles · 30d
- 14+ hour agolatest article
- Aug 15, 2026earliest in window
- 0%with images
- 303avg words
- News 577
- Economy, Business & Finance 538
- Finance & Business 452
- Politics 449
- Politics2 385
- Finance 157
- Business & Industrial 66
- Health & Wellness 63
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Press Release: Sean Casten and Elmhurst University Announce Federal Funding for Health Research Technology | Stock News
3+ day, 16+ hour ago (362+ words) Casten and Elmhurst University announced $950,000 in federal funding for health sciences research and simulation equipment. Funding announced at Elmhurst University: U.S. Rep. Sean Casten and Elmhurst University said the school will receive $950,000 in federal funding for instructional, simulation, and research equipment…...
Press Release: Shri Thanedar Leads Bipartisan Resolution for National Suicide Prevention Month | Stock News
3+ day, 14+ hour ago (375+ words) Bipartisan resolution designates September as Suicide Prevention Month, promoting mental health awareness and access to care. Lawmakers introduce suicide-prevention resolution: Rep. Shri Thanedar, joined by Reps. Wesley Bell and Mike Lawler, introduced a bipartisan resolution to recognize September as National…...
Press Release: Diana Harshbarger Introduces Bill to Update FDA Drug Preclusion Rules | Stock News
3+ day, 16+ hour ago (309+ words) Harshbarger proposes FDA reforms to clarify drug preclusion rules and protect dietary supplement access. Harshbarger proposal: Rep. Diana Harshbarger said she introduced the Dietary Supplement Innovation Act, which would update FDA “drug preclusion” rules and set clearer standards for when…...
Vistagen to Present Phase 3 Fasedienol Data in Severe Social Anxiety Disorder at Psych Congress | VTGN Stock News
4+ day, 37+ min ago (108+ words) Vistagen will present positive Phase 3 data for fasedienol nasal spray in social anxiety disorder at Psych Congress. Fasedienol nasal spray is a Phase 3 product candidate developed by Vistagen for the acute treatment of social anxiety disorder. Vistagen will present data…...
IMUNON Enters CRADA with NCI’s CTEP to Advance IMNN-001 in New Cancer Indications and Combinations | IMNN Stock News
3+ day, 23+ hour ago (300+ words) IMUNON partners with NCI's CTEP to explore new uses for IMNN-001 immunotherapy in clinical trials. The collaboration aims to evaluate IMNN-001 for new cancer indications and combination regimens. IMNN-001 is a DNA-based IL-12 immunotherapy developed by IMUNON for treating advanced ovarian…...
SS Innovations Reports Global Expansion, Pediatric Robotic Surgery and Telesurgery Milestones for SSi Mantra | SSII Stock News
4+ day, 37+ min ago (250+ words) SS Innovations has advanced its SSi Mantra system for pediatric and cardiac surgeries, expanding its global installations and utilization. The SSi Mantra has recently launched in Colombia and Sri Lanka, performing significant robotic surgeries and expanding capabilities. As of August…...
Oncolytics Biotech Reports Preclinical Pelareorep Activity Maintained with RAS Inhibition | ONCY Stock News
4+ day, 58+ min ago (287+ words) The study found that pelareorep maintains its activity alongside RAS inhibition, enhancing tumor reduction without antagonism. Pelareorep selectively replicates in tumor cells and activates both innate and adaptive anti-tumor immune responses. The research focuses on RAS-driven colorectal cancer and other…...
Disc Medicine Reports Positive Initial RESTORE-PV Results for DISC-3405 in Polycythemia Vera | IRON Stock News
4+ day, 13+ hour ago (249+ words) Initial results from RESTORE-PV show DISC-3405 improves symptoms in polycythemia vera by increasing hepcidin and reducing phlebotomy needs. The RESTORE-PV trial showed that DISC-3405 increased hepcidin, lowered serum iron, and reduced phlebotomy in PV patients. DISC-3405 is a monoclonal antibody…...
Fate Therapeutics to Present FT819 and FT839 Data at CCR West Meeting, Highlighting Safety and Efficacy in Autoimmune Disease | FATE Stock News
5+ day, 2+ hour ago (282+ words) 50% off your first year of any Quiver subscription Fate Therapeutics announces clinical and preclinical data on CAR T-cell therapies at CCR-West meeting, highlighting safety and efficacy in lupus treatment. FT819 is an off-the-shelf anti-CD19 CAR T-cell therapy showing promising safety and…...
Press Release: Bresnahan Announces $475,175 Grant for Luzerne County Community College Nursing Program | Stock News
4+ day, 20+ hour ago (397+ words) 50% off your first year of any Quiver subscription Representative Bresnahan announced a $475,175 federal grant to expand LCCC’s nursing program and healthcare workforce training. Grant announced for nursing program: Rep. Rob Bresnahan said Luzerne County Community College has received a $475,175 federal…...